Cytek Biosciences
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Cytek Biosciences's balance sheet done over the years? Its assets were worth $494,457,000 last year, which is less than in the previous period. 21% of Cytek Biosciences’s total assets is currently financed by debt. Its liabilities reached the amount of $101,393,000, which means an increase by 8% compared compared to last year.

Debt to Assets

Cytek Biosciences, Inc. (NASDAQ:CTKB): Debt to assets
2019 70361000 112.06M 159.27%
2020 219979000 236.00M 107.29%
2021 463700000 56.89M 12.27%
2022 519476000 93.93M 18.08%
2023 494457000 101.39M 20.51%

CTKB Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
167.29M296.60M364.61M165.23M30.12M
Short term investments
95.11M44.54M000
Net receivables
56.12M48.86M29.76M18.10M17.74M
Inventory
60.87M48.15M32.17M23.01M18.43M
Other current assets
12.65M12.95M5.50M445K301K
Total current assets
392.06M454.02M432.05M208.62M67.76M
Non-current assets:
Property, Plant and Equipment
29.25M27.56M5.85M2.14M1.04M
Goodwill
16.18M10.14M10.14M476K476K
Intangible assets
23.08M4.33M4.73M274K263K
Long term investments
1.6M1.6M00250K
Other non-current assets
1.78M1.35M1.66M1.08M-63K
Total non-current assets
102.39M65.45M31.64M11.35M2.59M
Total assets
494.45M519.47M463.7M219.97M70.36M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
22.69M12.98M7.08M4.28M3.47M
Short term debt
3.00M3.51M15.25M2.77M7.21M
Total current liabilities
56.22M49.04M32.16M26.53M21.03M
Non-current liabilities:
Long term debt
11.12M14.58M-777K-404K-629K
Deferred tax
00000
Other non-current liabilities
18.90M13.13M14.94M206.01M89.24M
Total non-current liabilities
45.16M44.89M24.73M209.47M91.02M
Total liabilities
101.39M93.93M56.89M236.00M112.06M
Data sourceData sourceData source